Kodiak Sciences logo

Kodiak Sciences Share Price (NASDAQ: KOD)

$9.03

0.06

(0.67%)

Last updated on

Check the interactive Kodiak Sciences Stock chart to analyse performance

Kodiak Sciences stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$8.68
    Today's High:$9.07

    Day's Volatility :4.3%

  • 52 Weeks Low:$1.92
    52 Weeks High:$11.60

    52 Weeks Volatility :83.45%

Kodiak Sciences Stock Returns

PeriodKodiak Sciences IncSector (Health Care)Index (Russel 2000)
3 Months
151.94%
3.6%
0.0%
6 Months
132.56%
-7.7%
0.0%
1 Year
274.79%
-12.6%
0.0%
3 Years
-14.35%
10.2%
-4.1%

Kodiak Sciences Inc Key Stats

Check Kodiak Sciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$8.97
Open
$9.0
Today's High
$9.07
Today's Low
$8.68
Market Capitalization
$477.5M
Today's Volume
$607.8K
52 Week High
$11.5999
52 Week Low
$1.92
Revenue TTM
$0.0
EBITDA
$-188.9M
Earnings Per Share (EPS)
$-3.82
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-140.33%

Stock Returns calculator for Kodiak Sciences Stock including INR - Dollar returns

The Kodiak Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kodiak Sciences investment value today

Current value as on today

₹3,78,425

Returns

₹2,78,425

(+278.42%)

Returns from Kodiak Sciences Stock

₹2,73,140 (+273.14%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Kodiak Sciences Stock

34%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Kodiak Sciences Stock from India on INDmoney has increased by 34% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Kodiak Sciences Inc

  • Name

    Holdings %

  • Baker Bros Advisors LP

    32.77%

  • BlackRock Inc

    7.07%

  • Acadian Asset Management LLC

    3.68%

  • Vanguard Group Inc

    3.45%

  • Adage Capital Partners Gp LLC

    2.51%

  • ICONIQ Capital, LLC

    2.40%

Analyst Recommendation on Kodiak Sciences Stock

Rating
Trend

Sell

    7%Buy

    35%Hold

    57%Sell

Based on 14 Wall street analysts offering stock ratings for Kodiak Sciences(by analysts ranked 0 to 5 stars)

Kodiak Sciences Share Price Target

What analysts predicted

Downside of 19.71%

Target:

$7.25

Current:

$9.03

Kodiak Sciences share price target is $7.25, a slight Downside of 19.71% compared to current price of $9.03 as per analysts' prediction.

Kodiak Sciences Stock Insights

  • Price Movement

    In the last 7 days, KOD stock has moved down by -11.1%
  • KOD vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 125.4%

Kodiak Sciences Technicals Summary

Sell

Neutral

Buy

Kodiak Sciences is currently in a neutral trading position according to technical analysis indicators.

Kodiak Sciences Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Kodiak Sciences Inc logo
36.39%
132.56%
274.79%
-14.35%
-82.09%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Kodiak Sciences Inc

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), an unconjugated bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Organization
Kodiak Sciences
Employees
121
CEO
Dr. Victor Perlroth M.D.
Industry
Health Technology

Key Management of Kodiak Sciences Inc

NameTitle
Dr. Victor Perlroth M.D.
Co-Founder, Chairman, CEO & President
Mr. John A. Borgeson CPA, M.B.A.
Executive VP, CFO & Secretary
Dr. Dolly S. Chang M.D., M.P.H., Ph.D.
Chief Scientific Officer
Dr. Hong Liang Ph.D.
Senior Vice President of Development
Dr. Stephen Raillard Ph.D.
Senior Vice President of Chemical Development & Manufacturing
Ms. Almas Qudrat M.Sc.
Chief Quality Officer
Dr. J. Pablo Velazquez-Martin M.D.
Chief Medical Officer
Dr. Laurent Ducay Ph.D.
Senior VP of Biologics Development & Manufacturing

Important FAQs about investing in KOD Stock from India :

What is Kodiak Sciences share price today?

Kodiak Sciences share price today is $9.03 as on at the close of the market. Kodiak Sciences share today touched a day high of $9.07 and a low of $8.68.

What is the 52 week high and 52 week low for Kodiak Sciences share?

Kodiak Sciences share touched a 52 week high of $11.60 and a 52 week low of $1.92. Kodiak Sciences stock price today i.e. is closed at $9.03, lower by 22.15% versus the 52 week high.

How to invest in Kodiak Sciences Stock (KOD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kodiak Sciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kodiak Sciences Shares that will get you 0.1661 shares as per Kodiak Sciences share price of $9.03 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Kodiak Sciences Stock (KOD) from India?

Indian investors can start investing in Kodiak Sciences (KOD) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Kodiak Sciences stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Kodiak Sciences share’s latest price of $9.03 as on August 30, 2025 at 1:29 am IST, you will get 1.1074 shares of Kodiak Sciences. Learn more about fractional shares .

What are the returns that Kodiak Sciences has given to Indian investors in the last 5 years?

Kodiak Sciences stock has given -82.09% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?